Article
Significance of an epidermal growth factor receptor mutation in cerebrospinal fluid for carcinomatous meningitis.
Internal medicine (Tokyo, Japan) - 1 Jan 2007
Kanaji Nobuhiro, Bandoh Shuji, Nagamura Norihiro, Kushida Yoshio, Haba Reiji, Ishida Toshihiko
Abstract excerpt
We report a case of epidermal growth factor receptor (EGFR) inhibitor-sensitive lung adenocarcinoma with carcinomatous meningitis who showed a good response to gefitinib, an oral tyrosine kinase inhibitor of EGFR. This good response to gefitinib treatment was attributed to evidence of an EGFR mutation, L858R in exon 21, which was detected in a small amount of cerebrospinal fluid (CSF) before the positive CSF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
